Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FPQW3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,488
Award facts
- Contract value 100% obligated
- $18,488.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on July 1, 2025, with an ultimate completion date of July 2, 2025. The delivery order is for Trikafta 100-50-75 mg/150 mg, a prescription medication used in the treatment of cystic fibrosis. This award was issued without a set-aside designation, allowing the company to compete directly in the federal procurement marketplace. The contract represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive pharmaceutical products and medical supplies to Department of Defense healthcare facilities nationwide. The company's extensive contract portfolio with the DLA includes a diverse range of medications spanning oncology treatments, vaccines, contraceptive devices, and specialty pharmaceutical products. The DLA, operating under the Department of Defense, leverages its procurement authority to ensure military health facilities worldwide have access to essential medications and medical supplies through qualified vendors like DMS Pharmaceutical Group.
Quick answers
Who was awarded contract SPE2DB25FPQW3?
SPE2DB25FPQW3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 1, 2025.
How much is contract SPE2DB25FPQW3 worth?
The government has obligated $18,488 on SPE2DB25FPQW3.
Is contract SPE2DB25FPQW3 an order under another contract?
Yes. SPE2DB25FPQW3 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQW3 competed?
The extent of competition for SPE2DB25FPQW3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award